CAS 52508-87-9

5-fluoro-2-oxoindoline-3-carbaldehyde

Codes：SUNT-018

Application context (from source-drug indications)

胰腺神经内分泌肿瘤苹果酸舒尼替尼肾细胞癌苹果酸舒尼替尼胃肠道间质瘤苹果酸舒尼替尼骨肉瘤苹果酸舒尼替尼肉瘤苹果酸舒尼替尼淋巴瘤苹果酸舒尼替尼

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
苹果酸舒尼替尼Sunitinib Malate	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

苹果酸舒尼替尼优化路线steps: 3total yield: /

N1,N1-diethylethane-1,2-diamine→N-(2-(diethylamino)ethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide→ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate→2,4-dimethyl-1H-pyrrole-3-carboxylic acid→5-fluoro-2-oxoindoline-3-carbaldehyde

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

Supplier	Product	Price band	MOQ	Lead time	Qualifications
Qualified Partner — East China API Works	5-Fluoro-2-oxindole Pharmaceutical Intermediates	询价	询价	询价	—
Unibest Nantong cGMP Site	5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid Pharmaceutical Intermediates	询价	询价	询价	—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.